Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-03-06 16:13:25
Reporting Period:
Accepted Time:
2020-03-06 16:13:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643746 H. Lorence Kim C/o Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-04 20,000 $27.71 1,262,510 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.40 to $28.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.